Stay updated with breaking news from Mani Daneshmand. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good afternoon and welcome to the TransMedics First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
A relatively new method of heart transplantation, which allows for the use of hearts donated after circulatory death could expand the pool of available donor hearts by a projected 30%. Here's what's happening.
5,000 Patients Treated Globally The versatility and innovation of Abiomed's (NASDAQ: ABMD) Impella 5.5 with SmartAssist, a minimally-invasive forward flow heart pump, is leading to continued adoption
5,000 Patients Treated GloballyDANVERS, Mass.--(BUSINESS WIRE)--The versatility and innovation of Abiomed’s (NASDAQ: ABMD) Impella 5.5 with SmartAssist, a minimally-invasive forward flow heart pump, is leading to continued adoption of the game-changing technology by surgeons around the world. Today, Abiomed announce...
Abiomed (Nasdaq:ABMD) announced today that the first patient in Japan was successfully treated with its Impella 5.5 with SmartAssist.